Allobeauvericin B

Details

Top
Internal ID 60d6a8e4-01bb-4967-9861-059f4e678ab7
Taxonomy Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides
IUPAC Name (3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-6,12-bis[(2R)-butan-2-yl]-4,10,16-trimethyl-18-propan-2-yl-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C47H61N3O9/c1-10-31(5)40-43(52)49(8)36(27-33-21-15-12-16-22-33)45(54)57-39(30(3)4)42(51)48(7)37(28-34-23-17-13-18-24-34)46(55)58-41(32(6)11-2)44(53)50(9)38(47(56)59-40)29-35-25-19-14-20-26-35/h12-26,30-32,36-41H,10-11,27-29H2,1-9H3/t31-,32-,36+,37+,38+,39-,40-,41-/m1/s1
InChI Key PVURPIBDNQIDSO-SFWGZFQISA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C47H61N3O9
Molecular Weight 812.00 g/mol
Exact Mass 811.44078053 g/mol
Topological Polar Surface Area (TPSA) 140.00 Ų
XlogP 9.10
Atomic LogP (AlogP) 5.69
H-Bond Acceptor 9
H-Bond Donor 0
Rotatable Bonds 11

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of Allobeauvericin B

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8990 89.90%
Caco-2 - 0.7611 76.11%
Blood Brain Barrier + 0.6750 67.50%
Human oral bioavailability + 0.5143 51.43%
Subcellular localzation Mitochondria 0.4431 44.31%
OATP2B1 inhibitior + 0.5774 57.74%
OATP1B1 inhibitior + 0.8686 86.86%
OATP1B3 inhibitior + 0.9296 92.96%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior + 0.9870 98.70%
P-glycoprotein inhibitior + 0.8598 85.98%
P-glycoprotein substrate - 0.6412 64.12%
CYP3A4 substrate - 0.5084 50.84%
CYP2C9 substrate - 0.6039 60.39%
CYP2D6 substrate - 0.8462 84.62%
CYP3A4 inhibition - 0.6820 68.20%
CYP2C9 inhibition - 0.7669 76.69%
CYP2C19 inhibition - 0.7350 73.50%
CYP2D6 inhibition - 0.9369 93.69%
CYP1A2 inhibition - 0.8684 86.84%
CYP2C8 inhibition - 0.9299 92.99%
CYP inhibitory promiscuity - 0.8787 87.87%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.7507 75.07%
Carcinogenicity (trinary) Non-required 0.6030 60.30%
Eye corrosion - 0.9918 99.18%
Eye irritation - 0.9218 92.18%
Skin irritation - 0.7865 78.65%
Skin corrosion - 0.9388 93.88%
Ames mutagenesis - 0.5800 58.00%
Human Ether-a-go-go-Related Gene inhibition + 0.8481 84.81%
Micronuclear + 0.6700 67.00%
Hepatotoxicity + 0.7125 71.25%
skin sensitisation - 0.8913 89.13%
Respiratory toxicity + 0.7444 74.44%
Reproductive toxicity + 0.7556 75.56%
Mitochondrial toxicity + 0.7962 79.62%
Nephrotoxicity - 0.6428 64.28%
Acute Oral Toxicity (c) III 0.7240 72.40%
Estrogen receptor binding + 0.7287 72.87%
Androgen receptor binding + 0.7058 70.58%
Thyroid receptor binding + 0.5465 54.65%
Glucocorticoid receptor binding + 0.7367 73.67%
Aromatase binding + 0.5403 54.03%
PPAR gamma + 0.7478 74.78%
Honey bee toxicity - 0.9203 92.03%
Biodegradation - 0.8500 85.00%
Crustacea aquatic toxicity + 0.5200 52.00%
Fish aquatic toxicity + 0.9311 93.11%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2581 P07339 Cathepsin D 98.87% 98.95%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.31% 96.09%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 93.63% 95.56%
CHEMBL2265 P23141 Acyl coenzyme A:cholesterol acyltransferase 93.49% 85.94%
CHEMBL221 P23219 Cyclooxygenase-1 92.26% 90.17%
CHEMBL253 P34972 Cannabinoid CB2 receptor 85.65% 97.25%
CHEMBL1293249 Q13887 Kruppel-like factor 5 83.23% 86.33%
CHEMBL3401 O75469 Pregnane X receptor 81.63% 94.73%
CHEMBL1978 P11511 Cytochrome P450 19A1 80.75% 91.76%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
There are no matching plants.

Cross-Links

Top
PubChem 11147190
LOTUS LTS0185089
wikiData Q75056964